Liu, J, Lahousse, L, Nivard, MG, Bot, M, Chen, LM, van Klinken, JB, Thesing, CS, Beekman, M, van den Akker, EB, Slieker, RC, Waterham, E
, van der Kallen, CJH, de Boer, I, Li-Gao, RF, Vojinovic, D, Amin, N, Radjabzadeh, D, Kraaij, R, Alferink, LJM, Murad, SD, Uitterlinden, AG, Willemsen, G, Pool, R, Milaneschi, Y, van Heemst, D, Suchiman, HED, Rutters, F, Elders, PJM, Beulens, JWJ, van der Heijden, AAWA
, van Greevenbroek, MMJ, Arts, ICW, Onderwater, GLJ, van den Maagdenberg, AMJM, Mook-Kanamori, DO, Hankemeier, T, Terwindt, GM
, Stehouwer, CDA, Geleijnse, JM, 't Hart, LM, Slagboom, PE, van Dijk, KW, Zhernakova, A, Fu, JY, Penninx, BWJH, Boomsma, DI, Demirkan, A, Stricker, BHC & van Duijn, CM 2020, '
Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas',
Nature Medicine, vol. 26, no. 1, pp. 110-117.
https://doi.org/10.1038/s41591-019-0722-x